# Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis

> **NCT02463578** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 30 (estimated)

## Conditions studied

- Pneumococcal Infection
- ANCA-associated Vasculitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02463578
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2018-05
- **Final completion:** 2018-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463578, "Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT02463578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*